Research and development
Key indicators
Selected geographical area: Canada
-
298,850 full-time equivalents16,500
(annual change) -
$46.9 billion9.3%
(year-over-year change)
More research and development indicators
Selected geographical area: Canada
-
$16.6 billion4.5%
(annual change)
-
$15.1 billion-3.2%
(annual change)
Filter results by
Search HelpKeyword(s)
Survey or statistical program
Results
All (4)
All (4) ((4 results))
- Articles and reports: 88F0006X2007007Description:
Results from the Survey of Innovation 2003 raised some interesting questions. First, an unexpected one-third of establishments in R&D services were not innovative. According to the guidelines of the Oslo Manual, innovative establishments are those that introduced a new or significantly improved product or process on to the market or into production, within a specified interval. Second, many of these non-innovative establishments indicated that satisfying existing customers was irrelevant to their firms success. This was very different response from all other types of firms.
This working paper provides a potential explanation of these unexpected results, as well as an overview of available information on establishments in R&D services (NAICS 5417) in the context of professional services generally. The paper assembles descriptive data to show that non-innovative establishments in R&D services differ significantly from other non-innovative establishments and, while not innovative, they are nevertheless highly inventive. It presents some evidence to suggest that they are venture firms (firms relying on infusions of investment capital rather than revenues from sales to sustain their operations) and proposes a specific set of indicators that would facilitate resolution of the nature of firms in this industry group.
Release date: 2007-12-20 - Articles and reports: 88-003-X20060029246Geography: CanadaDescription:
While firms engaged in R&D services are part of the population of firms covered by the Research and Development in Canadian Industry (RDCI) survey and the Biotechnology Use and Development Survey (BUDS), this industry group is not covered by a typical industry survey. This means that there are no industry-specific figures for contribution to GDP or other typical measures of industrial activities and finances. However, data for the industry group are available from the Survey of Innovation 2003, along with other selected professional services. Data from that survey indicate that the establishments in R&D services in physical, engineering and life sciences may be part of a select and highly atypical group of firms and are discussed in this article.
Release date: 2006-06-27 - Articles and reports: 88-003-X20040037441Geography: CanadaDescription:
This article examines average research and development spending per firm and revenue growth. Using data from the Survey of Research and Development in Canadian Industry, it explores differences in research and development spending and revenue growth between high-growth and non-high-growth firms that reported strong employment growth.
Release date: 2004-10-29 - Articles and reports: 88-003-X20010025752Geography: CanadaDescription:
With revenues of almost $2 billion, what are the characteristics and activities of firms that use or develop biotechnology as an important part of their firm's activities? Human Health biotechnology dominates both the revenue and spending in the biotechnology sector. Read this enlightening article for further details including dicussion on the geographic location and size of Canadian biotechnology firms.
Release date: 2001-05-02
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (4)
Analysis (4) ((4 results))
- Articles and reports: 88F0006X2007007Description:
Results from the Survey of Innovation 2003 raised some interesting questions. First, an unexpected one-third of establishments in R&D services were not innovative. According to the guidelines of the Oslo Manual, innovative establishments are those that introduced a new or significantly improved product or process on to the market or into production, within a specified interval. Second, many of these non-innovative establishments indicated that satisfying existing customers was irrelevant to their firms success. This was very different response from all other types of firms.
This working paper provides a potential explanation of these unexpected results, as well as an overview of available information on establishments in R&D services (NAICS 5417) in the context of professional services generally. The paper assembles descriptive data to show that non-innovative establishments in R&D services differ significantly from other non-innovative establishments and, while not innovative, they are nevertheless highly inventive. It presents some evidence to suggest that they are venture firms (firms relying on infusions of investment capital rather than revenues from sales to sustain their operations) and proposes a specific set of indicators that would facilitate resolution of the nature of firms in this industry group.
Release date: 2007-12-20 - Articles and reports: 88-003-X20060029246Geography: CanadaDescription:
While firms engaged in R&D services are part of the population of firms covered by the Research and Development in Canadian Industry (RDCI) survey and the Biotechnology Use and Development Survey (BUDS), this industry group is not covered by a typical industry survey. This means that there are no industry-specific figures for contribution to GDP or other typical measures of industrial activities and finances. However, data for the industry group are available from the Survey of Innovation 2003, along with other selected professional services. Data from that survey indicate that the establishments in R&D services in physical, engineering and life sciences may be part of a select and highly atypical group of firms and are discussed in this article.
Release date: 2006-06-27 - Articles and reports: 88-003-X20040037441Geography: CanadaDescription:
This article examines average research and development spending per firm and revenue growth. Using data from the Survey of Research and Development in Canadian Industry, it explores differences in research and development spending and revenue growth between high-growth and non-high-growth firms that reported strong employment growth.
Release date: 2004-10-29 - Articles and reports: 88-003-X20010025752Geography: CanadaDescription:
With revenues of almost $2 billion, what are the characteristics and activities of firms that use or develop biotechnology as an important part of their firm's activities? Human Health biotechnology dominates both the revenue and spending in the biotechnology sector. Read this enlightening article for further details including dicussion on the geographic location and size of Canadian biotechnology firms.
Release date: 2001-05-02
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: